Christine Orr

2.5k total citations
15 papers, 836 citations indexed

About

Christine Orr is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Christine Orr has authored 15 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Christine Orr's work include Melanoma and MAPK Pathways (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Christine Orr is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Christine Orr collaborates with scholars based in Canada, United States and Netherlands. Christine Orr's co-authors include Klaus P. Hoeflich, Lori S. Friedman, Mark Merchant, Jocelyn Chan, Howard M. Stern, Suzanne van Dijk, Wei Wei Prior, David P. Davis, Michael Degtyarev and Judith Klumperman and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Christine Orr

15 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Orr Canada	10	569	241	171	75	63	15	836
Laure Voisin Canada	14	784 1.4×	75 0.3×	159 0.9×	90 1.2×	26 0.4×	24	1.1k
Klara R. Klein United States	18	550 1.0×	63 0.3×	249 1.5×	47 0.6×	20 0.3×	38	1.1k
Vidula Sukhatme United States	8	353 0.6×	108 0.4×	190 1.1×	24 0.3×	125 2.0×	17	751
Christopher L. Murriel United States	9	695 1.2×	164 0.7×	345 2.0×	171 2.3×	13 0.2×	13	1.1k
Morey L. Smith United States	15	701 1.2×	55 0.2×	234 1.4×	89 1.2×	25 0.4×	29	1.3k
Elena T. Chan Netherlands	8	501 0.9×	89 0.4×	173 1.0×	24 0.3×	18 0.3×	12	723
Ludovic Bénard United States	12	352 0.6×	85 0.4×	55 0.3×	30 0.4×	47 0.7×	17	765
Olivia Spleiss Switzerland	16	407 0.7×	66 0.3×	410 2.4×	40 0.5×	39 0.6×	28	971
Delphine Lissa United States	16	519 0.9×	193 0.8×	278 1.6×	37 0.5×	10 0.2×	22	877
Rotem Ben‐Hamo Israel	18	665 1.2×	77 0.3×	203 1.2×	69 0.9×	30 0.5×	26	1.2k

Countries citing papers authored by Christine Orr

Since Specialization

Citations

This map shows the geographic impact of Christine Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Orr more than expected).

Fields of papers citing papers by Christine Orr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Orr. The network helps show where Christine Orr may publish in the future.

Co-authorship network of co-authors of Christine Orr

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Orr. A scholar is included among the top collaborators of Christine Orr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Orr. Christine Orr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Orr, Christine, et al.. (2025). Neuroendocrine Breast Cancer-Associated Ectopic Adrenocorticotropic Hormone Syndrome Requiring Bilateral Adrenalectomy. Current Oncology. 32(4). 205–205. 1 indexed citations

Orr, Christine & Ranil Sonnadara. (2019). <p>Coaching by design: exploring a new approach to faculty development in a competency-based medical education curriculum</p>. Advances in Medical Education and Practice. Volume 10. 229–244. 36 indexed citations

Yen, Ivana, Fergus Shanahan, Mark Merchant, et al.. (2018). Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors. Cancer Cell. 34(4). 611–625.e7. 47 indexed citations

Kirouac, Daniel C., Gabriele Schaefer, Jocelyn Chan, et al.. (2017). Clinical responses to ERK inhibition in BRAF V600E-mutant colorectal cancer predicted using a computational model. npj Systems Biology and Applications. 3(1). 14–14. 50 indexed citations

Ramjeesingh, Ravi, et al.. (2016). Thrombocytosis as a predictor of poor prognosis in colorectal cancer patients.. Journal of Clinical Oncology. 34(4_suppl). 540–540. 1 indexed citations

Orr, Christine. (2016). Using Discovery Learning Pedagogies. SHILAP Revista de lepidopterología. 13(1). 8–21. 1 indexed citations

Ramjeesingh, Ravi, et al.. (2015). A retrospective analysis of the role of proton pump inhibitors on colorectal cancer disease survival.. Journal of Clinical Oncology. 33(15_suppl). e14517–e14517. 1 indexed citations

Orr, Christine, et al.. (2014). Long-Term Efficacy of Insulin Pump Therapy on Glycemic Control in Adults with Type 1 Diabetes Mellitus. Diabetes Technology & Therapeutics. 17(1). 49–54. 30 indexed citations

Choo, Edna F., Marcia Belvin, Jason Boggs, et al.. (2012). Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions. Drug Metabolism and Disposition. 40(5). 919–927. 28 indexed citations

10.

Hoeflich, Klaus P., Mark Merchant, Christine Orr, et al.. (2011). Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition. Cancer Research. 72(1). 210–219. 200 indexed citations

11.

Choo, Edna F., Marcia Belvin, Jocelyn Chan, et al.. (2010). Preclinical disposition and pharmacokinetics-pharmacodynamic modeling of biomarker response and tumour growth inhibition in xenograft mouse models of G-573, a MEK inhibitor. Xenobiotica. 40(11). 751–762. 17 indexed citations

12.

Hoeflich, Klaus P., Mark Merchant, Jocelyn Chan, et al.. (2009). Abstract A250: Preclinical combination efficacy and identification of biomarkers of MEK and PI3K inhibitors in phase I. Molecular Cancer Therapeutics. 8(12_Supplement). A250–A250. 1 indexed citations

13.

Degtyarev, Michael, Ann De Mazière, Christine Orr, et al.. (2008). Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. The Journal of Cell Biology. 183(1). 101–116. 347 indexed citations

14.

Cao, Zhe, Kathryn E. Bass, Sriram Balasubramanian, et al.. (2006). CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo. Molecular Cancer Therapeutics. 5(7). 1693–1701. 25 indexed citations

15.

Newton, Philip M., Christine Orr, Melisa J. Wallace, et al.. (2004). Deletion of N-Type Calcium Channels Alters Ethanol Reward and Reduces Ethanol Consumption in Mice. Journal of Neuroscience. 24(44). 9862–9869. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact